Kapitalo Investimentos’s Idexx Laboratories IDXX Stock Holding History

Kapitalo Investimentos’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-432	Closed	-$233K	–	238
2024 Q1	$233K	Buy	+432	New	+$236K	0.05%	227
2023 Q4	–	Sell	-998	Closed	-$436K	–	623
2023 Q3	$436K	Buy	998 +200	+25%	+$99.7K	0.06%	132
2023 Q2	$401K	Buy	+798	New	+$382K	0.07%	137

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kapitalo Investimentos's IDXX Position: Q2 2024 in Review

Kapitalo Investimentos sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 432 shares — an estimated $233K sold.

Kapitalo Investimentos first reported a position in IDXX in Q2 2023 and held it in 3 quarters. The position peaked at $436K in Q3 2023. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Kapitalo Investimentos reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
Kapitalo Investimentos sold 432 Idexx Laboratories shares in Q2 2024, an estimated $233K.
Kapitalo Investimentos first reported a position in Idexx Laboratories in Q2 2023 and held it in 3 quarters.
Kapitalo Investimentos's Idexx Laboratories position peaked at $436K in Q3 2023.
1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Kapitalo Investimentos's 13F filing for Q2 2024, filed 14 Aug 2024.